Abiopharma

Kodiak Sciences Announces Closing of $184 Million Public Offering of Common Stock including Full Exercise of Underwriters Option to Purchase Additional Shares

Kodiak Sciences Announces Closing of $184 Million Public Offering of Common Stock including Full Exercise of Underwriters Option to Purchase Additional Shares

Shareholder Alert: The Ademi Firm investigates whether VYNE Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders

Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

ResMed Inc. Daily Stock Update

Senti Biosciences Announces New Employment Inducement Grants

CareDx - CareDx Provides Notice of Proposed Derivative Settlement

embecta to Participate at the J.P. Morgan 2026 Healthcare Conference

CareDx Provides Notice of Proposed Derivative Settlement

Annovis Announces Open-Label Extension Study for Parkinsons Disease Patients